abcam
plc
consultation
ltip
awards
cambridge
united
kingdom
globe
newswire
abcam
plc
aim
abc
nasdaq
abcm
global
leader
supply
life
science
research
tools
announces
following
consultation
shareholders
group
overall
ltip
structure
performance
framework
including
proposed
changes
year
awards
determined
retain
existing
ltip
metrics
targets
contained
abcam
current
remuneration
policy
approved
shareholders
furthermore
abcam
intends
continue
consulting
shareholders
coming
months
relation
proposals
new
remuneration
policy
put
forward
shareholders
approval
information
please
contact
abcam
marc
perkins
company
secretary
james
staveley
vice
president
investor
relations
numis
nominated
advisor
joint
corporate
broker
garry
levin
duncan
monteith
huw
jeremy
abcam
plc
innovator
reagents
tools
abcam
purpose
serve
life
science
researchers
globally
achieve
mission
faster
providing
research
clinical
communities
tools
scientific
support
company
offers
highly
validated
biological
binders
assays
address
important
targets
critical
biological
pathways
already
pioneer
data
sharing
ecommerce
life
sciences
abcam
ambition
influential
company
life
sciences
helping
advance
global
understanding
biology
causes
disease
turn
drive
new
treatments
improved
health
fiscal
year
ended
june
abcam
worldwide
customer
base
consisted
approximately
life
science
researchers
actively
listening
collaborating
researchers
company
continuously
advances
portfolio
address
needs
transparent
programme
customer
reviews
datasheets
combined
validation
initiative
gives
researchers
increased
confidence
results
founded
headquartered
cambridge
uk
company
served
customers
countries
abcam
ordinary
shares
admitted
trading
aim
aim
abc
american
depositary
shares
began
trading
nasdaq
global
market
october
nasdaq
abcm
